UBS AM’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-65,534
| Closed | -$3.85M | – | 2585 |
|
2023
Q4 | $3.85M | Sell |
65,534
-232,660
| -78% | -$13.7M | ﹤0.01% | 1375 |
|
2023
Q3 | $13M | Sell |
298,194
-4,627
| -2% | -$202K | 0.01% | 870 |
|
2023
Q2 | $11.3M | Hold |
302,821
| – | – | 0.01% | 925 |
|
2023
Q1 | $11.3M | Buy |
302,821
+62,919
| +26% | +$2.34M | 0.01% | 925 |
|
2022
Q4 | $10.9M | Buy |
239,902
+37,976
| +19% | +$1.72M | 0.01% | 910 |
|
2022
Q3 | $14.1M | Sell |
201,926
-15,493
| -7% | -$1.08M | 0.01% | 857 |
|
2022
Q2 | $14.6M | Sell |
217,419
-70,241
| -24% | -$4.72M | 0.01% | 821 |
|
2022
Q1 | $23.7M | Sell |
287,660
-247,405
| -46% | -$20.3M | 0.01% | 799 |
|
2021
Q4 | $78.5M | Buy |
535,065
+128,065
| +31% | +$18.8M | 0.03% | 533 |
|
2021
Q3 | $72M | Sell |
407,000
-23,751
| -6% | -$4.2M | 0.03% | 539 |
|
2021
Q2 | $69.6M | Sell |
430,751
-33,339
| -7% | -$5.39M | 0.03% | 550 |
|
2021
Q1 | $79.5M | Sell |
464,090
-27,926
| -6% | -$4.78M | 0.04% | 482 |
|
2020
Q4 | $108M | Sell |
492,016
-154,280
| -24% | -$33.9M | 0.05% | 382 |
|
2020
Q3 | $107M | Buy |
646,296
+41,646
| +7% | +$6.92M | 0.06% | 321 |
|
2020
Q2 | $69M | Buy |
604,650
+6,187
| +1% | +$706K | 0.04% | 400 |
|
2020
Q1 | $46M | Buy |
598,463
+233,931
| +64% | +$18M | 0.03% | 462 |
|
2019
Q4 | $47M | Buy |
364,532
+128,939
| +55% | +$16.6M | 0.03% | 545 |
|
2019
Q3 | $18.4M | Buy |
235,593
+213,716
| +977% | +$16.7M | 0.01% | 786 |
|
2019
Q2 | $2.25M | Buy |
21,877
+11,117
| +103% | +$1.15M | ﹤0.01% | 1532 |
|
2019
Q1 | $789K | Buy |
10,760
+3,880
| +56% | +$284K | ﹤0.01% | 1906 |
|
2018
Q4 | $292K | Sell |
6,880
-2,220
| -24% | -$94.2K | ﹤0.01% | 2223 |
|
2018
Q3 | $429K | Buy |
9,100
+300
| +3% | +$14.1K | ﹤0.01% | 2151 |
|
2018
Q2 | $434K | Buy |
+8,800
| New | +$434K | ﹤0.01% | 2158 |
|